Alder BioPharmaceuticals
| Use attributes for filter ! | |
| Stock price | ALDR |
|---|---|
| Disclaimer | |
| Headquarters | Bothell |
| Washington | |
| United States | |
| Founded | 2002 |
| Subsidiary | Alderbio Holdings Llc |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1278666 |
About Alder BioPharmaceuticals
Alder Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Alder specializes in therapeutic monoclonal antibodies. Alder went public in May 2014. In early 2018, the company made a public stock offering, aiming to raise US$250 million.
